Delivery Order SPE2DB22D2206-SPE2DB24FFG65
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $41,648.94, is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract has an ultimate completion date of September 27, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $4,167.61, is a delivery order for Dupixent 300 mg/2 ml pens. The award has an ultimate completion date of February 15, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $16,523.50, is for the delivery of Dupixent 300 mg/2 ml pens for a period ending on January 24, 2024. This is a firm fixed-price delivery order contract, and there was no set-aside designation indicated. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in...
- This federal contract award, valued at $11,668.82, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a performance period through December 5, 2023. The contract is a Firm Fixed Price Delivery Order, and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $8,456.60, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a completion date of February...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pens. The $21,622.78 firm-fixed-price delivery order falls under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pens. The $5,083.16 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., that supports the DLA Troop Support Medical in providing pharmaceutical products and medical supplies to military treatment...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,304.72 firm fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract has a ceiling value of $3,304.72 and a completion date of November 7, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,448.11 firm fixed-price delivery order has a completion date of September 8, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products, including Dupixent 300 mg/2 ml pens. The contract, valued at $16,272.14, has a completion date of June 5, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFG65Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $10,721.75, is a delivery order for the pharmaceutical product Dupixent 300 mg/2 ml pen with an ultimate completion date of January 26, 2024. The contract is a firm fixed-price arrangement, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to $999,999,999.00, as well as the Department of Justice Federal Bureau of Investigation, valued at up to $750,000. These IDCs enable the efficient procurement of essential pharmaceutical and medical supplies to support military, veteran, and other federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 1/25/24 |